178 related articles for article (PubMed ID: 17493035)
1. Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease.
Maat-Schieman M; Roos R; Losekoot M; Dorsman J; Welling-Graafland C; Hegeman-Kleinn I; Broeyer F; Breuning M; van Duinen S
Brain Pathol; 2007 Jan; 17(1):31-7. PubMed ID: 17493035
[TBL] [Abstract][Full Text] [Related]
2. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.
Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA
Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478
[TBL] [Abstract][Full Text] [Related]
3. The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade.
Hickman RA; Faust PL; Marder K; Yamamoto A; Vonsattel JP
Acta Neuropathol Commun; 2022 Apr; 10(1):55. PubMed ID: 35440014
[TBL] [Abstract][Full Text] [Related]
4. Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain.
Maat-Schieman ML; Dorsman JC; Smoor MA; Siesling S; Van Duinen SG; Verschuuren JJ; den Dunnen JT; Van Ommen GJ; Roos RA
J Neuropathol Exp Neurol; 1999 Feb; 58(2):129-37. PubMed ID: 10029096
[TBL] [Abstract][Full Text] [Related]
5. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.
Wanderer J; Morton AJ
Histochem Cell Biol; 2007 May; 127(5):473-84. PubMed ID: 17285342
[TBL] [Abstract][Full Text] [Related]
6. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
[TBL] [Abstract][Full Text] [Related]
7. Optineurin in Huntington's disease intranuclear inclusions.
Schwab C; Yu S; McGeer EG; McGeer PL
Neurosci Lett; 2012 Jan; 506(1):149-54. PubMed ID: 22085693
[TBL] [Abstract][Full Text] [Related]
8. Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.
Rüb U; Hentschel M; Stratmann K; Brunt E; Heinsen H; Seidel K; Bouzrou M; Auburger G; Paulson H; Vonsattel JP; Lange H; Korf HW; den Dunnen W
Brain Pathol; 2014 Apr; 24(3):247-60. PubMed ID: 24779419
[TBL] [Abstract][Full Text] [Related]
9. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
[TBL] [Abstract][Full Text] [Related]
10. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF
J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
[TBL] [Abstract][Full Text] [Related]
12. The selective vulnerability of nerve cells in Huntington's disease.
Sieradzan KA; Mann DM
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
[TBL] [Abstract][Full Text] [Related]
14. Expanded polyglutamine impairs normal nuclear distribution of fused in sarcoma and poly (rC)-binding protein 1 in Huntington's disease.
Mori S; Honda H; Ishii T; Yoshimura M; Sasagasako N; Suzuki SO; Taniwaki T; Iwaki T
Neuropathology; 2019 Oct; 39(5):358-367. PubMed ID: 31599037
[TBL] [Abstract][Full Text] [Related]
15. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Gourfinkel-An I; Cancel G; Duyckaerts C; Faucheux B; Hauw JJ; Trottier Y; Brice A; Agid Y; Hirsch EC
Neuroreport; 1998 Jun; 9(8):1823-6. PubMed ID: 9665608
[TBL] [Abstract][Full Text] [Related]
16. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?
Davies SW; Beardsall K; Turmaine M; DiFiglia M; Aronin N; Bates GP
Lancet; 1998 Jan; 351(9096):131-3. PubMed ID: 9439509
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.
Ribeiro FM; Devries RA; Hamilton A; Guimaraes IM; Cregan SP; Pires RG; Ferguson SS
Hum Mol Genet; 2014 Apr; 23(8):2030-42. PubMed ID: 24282028
[TBL] [Abstract][Full Text] [Related]
18. The early cellular pathology of Huntington's disease.
Li XJ
Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117
[TBL] [Abstract][Full Text] [Related]
19. Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice.
Kurosawa M; Matsumoto G; Kino Y; Okuno M; Kurosawa-Yamada M; Washizu C; Taniguchi H; Nakaso K; Yanagawa T; Warabi E; Shimogori T; Sakurai T; Hattori N; Nukina N
Hum Mol Genet; 2015 Feb; 24(4):1092-105. PubMed ID: 25305080
[TBL] [Abstract][Full Text] [Related]
20. Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1.
Mouro Pinto R; Arning L; Giordano JV; Razghandi P; Andrew MA; Gillis T; Correia K; Mysore JS; Grote Urtubey DM; Parwez CR; von Hein SM; Clark HB; Nguyen HP; Förster E; Beller A; Jayadaev S; Keene CD; Bird TD; Lucente D; Vonsattel JP; Orr H; Saft C; Petrasch-Parwez E; Wheeler VC
Hum Mol Genet; 2020 Aug; 29(15):2551-2567. PubMed ID: 32761094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
